A large study has found that GLP-1s may be linked to a lower risk of multiple cancers. The specific types of cancer that may have a lower risk include breast, pancreatic, and colorectal cancer, although the details and extent of these links are not entirely clear. Some reports also suggest potential benefits of GLP-1s beyond cancer risk, but the focus of the research appears to be on their possible role in reducing cancer risk.